Immunogenicity of reduced antigen content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine

Vaccine

Volumn 25, Issue 29, 2007, Pages 5248-5252

  Zepp, Fred ^a   Habermehl, Pirmin ^a   Knuf, Markus ^a   Mannhardt Laakman, Wilma ^a   Howe, Barbara ^b   Friedland, Leonard R ^b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b GLAXOSMITHKLINE   (United States)

Author keywords

Adolescent; Immunogenicity; Tdap vaccination

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; HEPATITIS A VACCINE;

ADOLESCENT; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; GERMANY; HEPATITIS A; HUMAN; IMMUNOGENICITY; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; PERTUSSIS; PRIORITY JOURNAL; SCHOOL CHILD; SINGLE DRUG DOSE; VACCINATION;

ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; CHILD; DIPHTHERIA; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; DOUBLE-BLIND METHOD; FEMALE; HEPATITIS A VACCINES; HUMANS; IMMUNIZATION, SECONDARY; MALE; TETANUS; TIME FACTORS; WHOOPING COUGH;

EID: 34250840554     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.05.012     Document Type: Article

References (15)

1. Zepp F., Knuf M., Habermehl P., Mannhardt-Laakmann W., Howe B., and Friedland L.R. Safety of reduced antigen content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a 6th consecutive dose of acellular-pertussis containing vaccine. J Pediatr 149 (2006) 603-610
2. ® package insert.
3. ® package insert.
4. Pichichero M.E., Blatter M.M., Kennedy W.A., Hedrick J., Descamps D., and Friedland L.R. Acellular pertussis vaccine booster combined with diphtheria and tetanus toxoids for adolescents. Pediatrics 117 (2006) 1084-1093
5. Schmitt H.-J., Schuind A., Knuf M., Beutel K., Schulte-Wissermann H., Gahr M., et al. Clinical experience of a tricomponent acellular pertussis vaccine combined with diphtheria and tetanus toxoids for primary vaccination in 22,505 infants. J Pediatr 129 (1996) 695-701
6. Turnbull F.M., Heath T.C., Jalaludin B.B., Burgess M.A., and Ramalho A.C. A randomized trial of two acellular pertussis vaccines (dTpa and pa) and a licensed diphtheria-tetanus vaccine (Td) in adults. Vaccine 19 (2000) 628-636
7. Tran Minh N.N., He Q., Ramalho A., Kaufhold A., Viljanen M.K., Arvilommi H., et al. Acellular vaccines containing reduced quantities of pertussis antigens as a booster in adolescents. Pediatrics 104 (1999). http://www.pediatrics.org/cgi/content/full/104/6/e70 Available from: http://www.pediatrics.org/cgi/content/full/104/6/e70.
8. Southern J., Andrews N., Burrage M., and Miller E. Immunogenicity and reactogenicity of combined acellular pertussis/tetanus/low dose diphtheria vaccines given as a booster to UK teenagers. Vaccine 23 (2005) 3829-3835
9. Kosuwon P., Warachit B., Hutagalung Y., Borkird T., Kosalaraksa P., Bock H.L., et al. Reactogenicity and immunogenicity of reduced antigen content diphtheria-tetanus-acellular pertussis vaccine (dTpa) administered as a booster to 4-6 year-old children primed with four doses of whole-cell pertussis vaccine. Vaccine 21 (2003) 4194-4200
10. Centers for Disease Control Prevention. Preventing tetanus, diphtheria and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 55 No. RR-3 (2006)
11. Pichichero M.E., Casey J.R., Francis A.B., Marsocci S.M., Murphy M., Hoeger W., et al. Acellular pertussis vaccine boosters combined with diphtheria and tetanus toxoid boosters for adolescents: safety and immunogenicity assessment when preceded by different five-dose DtaP/DTwP schedules. Clin Pediatr 45 (2006) 613-620
12. Schmitt H., Wirsing von König C., Neiss A., Bogaerts H., Bock H.L., Schulte-Wissermann H., et al. Efficacy of acellular pertussis vaccine in early childhood after household exposure. JAMA 275 (1996) 37-41
13. Simonsen O. Vaccination against diphtheria and tetanus: evaluation of immunity in the Danish population, guidelines for revaccination, and methods for control of vaccination programs. Danish Med Bull 36 (1989) 24-27
14. Blennow M., and Granstrom M. Long-term serologic follow-up after pertussis immunization. Pediatr Infect Dis 9 (1990) 21-26
15. Grimprel E., Begue P., Anjak I., Njamkepo E., Francois P., and Guiso N. Long-term human serum antibody responses after immunization with whole-cell pertussis vaccine in France. Clin Diag Lab Immun 3 (1996) 93-97